Literature DB >> 29249676

Refining the cross-finger flap: Considerations of flap insetting, aesthetics and donor site morbidity.

Chew-Wei Chong1, Cheng-Hung Lin2, Yu-Te Lin1, Chung-Chen Hsu1, Shih-Heng Chen1.   

Abstract

We described a laterally based cross-finger flap for reconstruction of soft tissue defects in the fingers. This modification enables coverage of volar or dorsal soft tissue defects at the distal, middle or proximal phalanx. From March 2015 to January 2017, a total of 12 patients (13 fingers) underwent soft tissue reconstruction of the fingers with a laterally based cross-finger flap. The flap dimensions ranged from 13 ×7 mm to 43 ×13 mm. Eleven of the 13 flaps survived completely. The two flap failures were attributed to injuries in the donor fingers, rendering the blood supply of the flaps unreliable. All donor sites were closed primarily without the need for skin grafting, negating the problem of donor site morbidity that is associated with skin graft harvesting. The laterally based cross-finger flap is a versatile flap with less donor site morbidity and better aesthetics than a conventional cross-finger flap. We described the design of the flap, as well as the advantages and disadvantages, in doing a laterally based cross-finger flap.
Copyright © 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cross-finger flap; Fingertip reconstruction; Glabrous skin; Pulp reconstruction

Mesh:

Year:  2017        PMID: 29249676     DOI: 10.1016/j.bjps.2017.11.014

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  1 in total

1.  Propeller perforator flaps from the dorsal digital artery perforator chain for repairing soft tissue defects of the finger.

Authors:  Haoliang Hu; Hong Chen; Jinjiong Hong; Weisheng Mao; Mintao Tian; Liping Wang; Jianghui Dong; Xueyuan Li
Journal:  BMC Surg       Date:  2019-12-11       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.